ACIP Recommends Catch-Up HPV Vaccines Through Age 26
Catch-up HPV vaccinations are recommended for all persons through age 26 years and should be considered for some persons aged 27 to 45 years.
Human Papillomavirus
European Society of Gynecologic Oncology Supports HPV Vaccination for Children
Since vaccines against HPV were made available in Europe in 2006, they have been highly effective in preventing infection and disease by the vaccine types.
ACIP Votes to Expand HPV Vaccination Recommendations
The CDC ACIP has voted to expand routine and catch-up HPV vaccination in males through 26 years of age who are inadequately vaccinated.
HPV16 Antibodies Can Develop Long Before Throat Cancer Diagnosis
Seroconversion to human papillomavirus type 16 -E6 antibody positivity can occur decades before diagnosis of oropharyngeal squamous cell carcinoma.
HPV Viral Loads Correlated Between Heterosexual Couples
Persistent human papillomavirus infections may have minimal changes in viral load
Quadrivalent HPV Vaccine Less Effective in Immunocompromised Youth
Antibody titers to the HPV4 vaccine were lower for all HPV serotypes in individuals who were infected with HIV perinatally than those who were exposed to HIV perinatally.
Histologic Clearance of CIN2/3 Seen With HPV Therapeutic Vaccine
Rate of complete resolution of CIN2/3 significantly higher for HPV vaccine group versus placebo group.
Hand-To-Genital Transmission of HPV Between Heterosexual Partners
Transmission of human papillomavirus is unlikely to occur from hand-to-genital contact.
High-Risk HPV May Be Associated With CVD in Korean Women
High-risk human papillomavirus infection may be associated with the risk for cardiovascular disease in Korean women.
HPV Infection Unlikely to Spread From Hand Contact
The majority of genital HPV infections are likely to be caused by genital-to-genital sexual transmission, not hand-to-genital contact.
Next post in News
